南美洲和中美洲过敏反应治疗市场预测至 2028 年 - COVID-19 影响和按药物类型（肾上腺素、抗组胺药、类固醇、β 激动剂等）、给药途径（口服、肠胃外等）、过敏类型进行的区域分析（食物过敏、药物、昆虫叮咬等）和分销渠道（医院药房、零售等）
No. of Pages: 136 | Report Code: TIPRE00023955 | Category: Life Sciences
No. of Pages: 136 | Report Code: TIPRE00023955 | Category: Life Sciences
过敏反应是一种过敏反应，可进一步导致称为过敏性休克的致命疾病。当患者的身体对异物产生反应并产生大量组胺从而引发炎症反应时，就会发生过敏反应。这是一种严重的、危及生命的过敏反应，其症状包括吞咽和呼吸困难、皮肤瘙痒和血压降低。
因此，过敏反应发生率的上升预计将对过敏反应产生巨大的需求未来几年的治疗，预计这将进一步推动过敏反应治疗市场。
COVID-19 的爆发严重影响了该地区的医疗服务流动。此外，这些国家的医疗旅游也很受欢迎，这也受到了疫情的影响。巴西、阿根廷、秘鲁、智利、乌拉圭、哥伦比亚受到第二波新冠感染的影响。其中巴西的死亡人数最多。截至 2021 年 5 月，巴西已有约 411,854 人丧生，这是第二波新冠病毒感染的迹象。预计该地区可能会实施第二次封锁，这最终将阻碍该地区的医疗保健行业。此外，各国的医疗资源严重依赖美国和欧洲国家。因此，该地区的市场经历了显着的放缓，预计未来一到两年也将面临同样的情况。此外，巴西人民越来越意识到 COVID-19 及其治疗导致哮喘或过敏性疾病加重的风险，这促进了世界其他地区过敏反应治疗市场的增长。这些因素对南美洲和中美洲过敏反应治疗市场产生潜在影响。
南美洲和中美洲的过敏反应治疗市场预计将增长从 2021 年的 9190 万美元增加到 2028 年的 1.575 亿美元；预计 2021 年至 2028 年复合年增长率为 8.0%。接种 COVID-19 疫苗后已观察到过敏病例。除此之外，有过敏反应史的患者应携带肾上腺素自动注射器，以便在预约疫苗接种时携带。随着这一举措的实施，COVID-19 疫苗接种场所应始终准备好至少三剂肾上腺素，并能够在给患者注射肾上腺素后更换用品。然而，作为 AEFI 的过敏反应并不常见，大多数疫苗的发生率不到百万分之一。这些因素为当前 COVID-19 情况下过敏反应治疗市场的增长提供了机会。
从药物类型来看，2020年中南美洲过敏反应治疗市场中，肾上腺素细分市场占据最大份额。从给药途径来看，注射给药细分市场占据了最大份额。 2020年南美洲和中美洲过敏反应治疗市场份额最大。就过敏类型而言，食物过敏部分占2020年南美洲和中美洲过敏反应治疗市场最大份额。就分销渠道而言，零售药店2020年，该细分市场在过敏反应治疗市场中占有更大的市场份额。
准备本南美洲和中美洲过敏反应治疗市场报告时提到的一些主要一手和二手资料包括公司网站、年度报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司包括 Amneal Pharmaceuticals Inc.、Mylan NV、Abbott、Pfizer Inc.、Glaxosmithkline Plc.、Merck and Co., Inc.、Teva Pharmaceutical Industries Ltd. 和 ALK-ABELLó。
< p>按药物类型
按给药途径
按过敏类型
按分销渠道
按国家/地区
Strategic insights for South and Central America Anaphylaxis Treatment involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 91.9 Million |
| Market Size by 2028 | US$ 157.5 Million |
| Global CAGR (2021 - 2028) | 8.0% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 药物类型
|
| Regions and Countries Covered | 南美洲和中美洲
|
| Market leaders and key company profiles |
The regional scope of South and Central America Anaphylaxis Treatment refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The South and Central America Anaphylaxis Treatment Market is valued at US$ 91.9 Million in 2021, it is projected to reach US$ 157.5 Million by 2028.
As per our report South and Central America Anaphylaxis Treatment Market, the market size is valued at US$ 91.9 Million in 2021, projecting it to reach US$ 157.5 Million by 2028. This translates to a CAGR of approximately 8.0% during the forecast period.
The South and Central America Anaphylaxis Treatment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Anaphylaxis Treatment Market report:
The South and Central America Anaphylaxis Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South and Central America Anaphylaxis Treatment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South and Central America Anaphylaxis Treatment Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South and Central America Anaphylaxis Treatment Market
